Somatic mutation in the mitochondrial genome occurs much more rapidly than in the nuclear genome and is a feature, possibly contributory, of the aging of cells and tissues. Identifying mitochondrial sequence changes in blood DNA of elderly subjects may provide a maker for the epigenetic changes of mitochondrial DNA known to occur in tissues with lower cellular turnover, and would also have implications for immunosenescence. No large-scale epidemiological studies have been reported previously. In this study we have established long-PCR banks of the mitochondrial genome from peripheral lymphocytes for an elderly cohort of 716 individuals with a range of measured aging phenotypes, and we have established assays for three widely reported mutations: the 4977 bp and 8048 bp deletions and point mutation A3243G. No individuals were identified with detectable heteroplasmy for these changes. Implications for tissue and population prevalence are discussed. The mitochondrial long-PCR DNA banks established will be useful for a wide range of studies of somatic mutation and of germline haplotypes in relation to aging.
Introduction
The mechanisms of aging are still not fully understood, but there are several prevailing hypotheses. One of these hypotheses, termed the mitochondrial theory of aging, suggests that aging is attributable to a failure in maintaining normal mitochondrial function. Mitochondria are present in almost all mammalian cells, and are responsible for energy generation. Each mitochondrion contains between two and ten copies of circular mitochondrial DNA (mtDNA), which has a mutation rate 5-10-fold greater than that of nuclear DNA. This is due to the high concentration of mutagenic reactive oxygen species in the mitochondrion, a lack of protective histone proteins and an inefficient DNA repair mechanism.
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bioenergetic function, thus contributing to aging. Three different types of mtDNA mutation have been reported, namely deletions, short duplications and base substitutions. The most common mtDNA deletion arises from loss of a 4977 bp sequence from nucleotide position 8470 to 13447, and is referred to as mtDNA 4977 or the 'common' deletion. Another age-associated large deletion of 8048 bp has also been identified [1] . This mutation spans the 4977 bp region and further flanking regions leftward and rightward. A point mutation arising from an A → G substitution at position 3243 on the mitochondrial L strand has also been detected in senescent individuals [2] .
Aging affects many systems of the body, including the immune system. A decline in immune system function is responsible for the increased susceptibility of the elderly to infections, malignancies and autoimmune diseases. This age-related immunodeficiency is related to a decline in the number and function of lymphocytes, which is thought to be attributable to the accumulation of mtDNA mutations in these cells. In in vitro cultured human lymphocytes, there is an age-associated accumulation of mtDNA mutations; however, it is unclear whether this also occurs in vivo. In the present study, we investigated whether mtDNA mutations could be detected in lymphocytic DNA in peripheral blood from aging individuals. To address these questions, we screened for widely known mtDNA mutations in a cohort of 716 elderly British Caucasian subjects for whom detailed measurements of aging phenotypes were available. We also report here a method that allows the detection of deletions in any region of the mitochondrial genome, and which is conservative of the original DNA bank, and is convenient, specific and sensitive for studies of mitochondrial mutations.
Methods
We studied a cohort of 716 individuals (411 men and 305 women). Mean age was 67.5 ± 2.4 years. All subjects underwent measurement of grip strength, anthropometry, hearing and an eye examination, details of which have been described previously [3] .
DNA was extracted from blood, and two sets of long PCR were carried out. The first PCR covered an 8 kb sequence from nucleotide 16 201 to 7631, and was carried out with the following primers: 5 -GAAAGGTGATAAGCTCTTCT-ATGAT-3 (mt5; forward primer) and 5 -CAAGCAAGT-ACAGCAATCAACCCTC-3 (mt6; reverse primer). The second PCR covered a 9.5 kb region from nucleotide positions 6964 to 16 527, and was carried out with primers mt7 (5 -CAAGCAAGTACAGCAATCAACCCTC-3 ; forward primer) and mt8 (5 -GAAAGGTGATAAGCTCTT-CTATGAT; reverse primer). The second PCR covers the two gross deletions mentioned in the Introduction.
Allele-specific amplification, which is considered to be more sensitive than the PCR/restriction-fragment-length polymorphism method for identifying lower degrees of heteroplasmy, was used to detect the A → G mutation at position 3243 [2] .
The study was approved by the local ethics committee, and all subjects gave informed consent to participation.
Results
These two sets of long PCR together allow the detection of the majority of reported and novel deletions in mtDNA, whereas using only one set would not. For example, one of these two sets of long PCR would not detect the mtDNA 4977 and 8048 kb mutations, because these deletions involve the DNA sequences to which the primers anneal (Figure 1 ). For detecting the 3243 A → G point mutation, we carried out allelic-specific PCR using products of the long PCRs as templates. Using this method, the 3243 A → G mutation was detected in the DNA extracted from a muscle biopsy from a patient with mitochondrial MELAS (mitochondrial encephalopathy, lactic acidosis and stroke-like episodes) syndrome. This demonstrated that long-PCR products could be used as templates for secondary PCRs to detect mtDNA mutations, and thus it is feasible to use long-PCR products from different individuals as a 'mtDNA bank' in order to conserve DNA samples if a large number of mutations are to be analysed. The principle of a mtDNA bank could be applied to other types of tissue.
We then used the above assays to screen for deletions and for the 3243 A → G mutation in a cohort of 716 individuals aged between 64 and 74 years. No mutation was identified in blood DNA from any of these subjects.
Discussion
Accumulation of age-related mutations in mtDNA occurs in a number of tissues, including brain, muscle, skin, kidney and lung. It is possible that mtDNA in lymphocytes undergoes similar mutational changes during aging, and this may contribute to immunosenescence and other agerelated phenotypes. On the other hand, compared with the tissues mentioned above, lymphocytes have a higher turnover rate and a shorter life span, which would limit the accumulation of mtDNA mutations. Large deletions and single-base substitutions are the most common types of mutation in the mitochondrial genome. In the present study, we screened for two large deletions and for a common singlebase substitution (i.e. 3243 A → G) in peripheral blood DNA samples from a large cohort of elderly subjects, and did not observe such mutations. These results are consistent with data from a study of mtDNA heteroplasmy in blood [4] , and suggest that there is no significant accumulation of any mtDNA deletion or of the 3243 A → G mutation in lymphocytes, even among a large number of elderly individuals.
To our knowledge, the present study is the first to explore the possibility of age-related mtDNA mutations in a large cohort of subjects. For large epidemiological studies, blood DNA is one of very few feasible sources. Although the absence of significant accumulation of mutations in blood mtDNA does not exclude the possibility that somatic mutations may exist in other tissues in the same individuals, homoplasmic germline mutations should be evident, independent of DNA source. Although most large deletions in mtDNA are somatic mutations, large germline deletions in mtDNA have been reported. In particular, large germline deletions in mtDNA have been found in patients with mitochondrial diseases, including mitochondrial myopathies, mitochondrial encephalomyopathy, progressive external ophthalmoplegia (CPEO), and Kearns-Sayre syndrome [5] [6] [7] .
The mutations screened in the present study are involved in the development of various diseases. For example, the mtDNA 4977 mutation has been found in the brains of patients with Parkinson's disease [8] , while the 3243 A → G mutation has been found in patients with MELAS syndrome [9] . A study by Hammans et al. [10] has shown that, in MELAS patients, the percentage of mtDNA carrying this mutation is higher in muscle than in blood samples, and that the percentage of mutant mtDNA in both blood and muscle samples correlates with the age of onset of symptoms [10] .
The design of the long PCRs in the present study would permit the detection of the majority of reported and novel A B large deletions in mtDNA. The use of two long PCRs with overlapping amplication to cover the mitochondrial genome is superior to the use of one long PCR, as the latter would not detect deletions spanning the sites to which the primers anneal. These new PCR assays represent useful tools in studying mtDNA deletions, not only in aging but also in other conditions. In conclusion, the results of the present study indicate that there is no significant accumulation of large deletions or of the 3243 A → G mutation in mtDNA in lymphocytes in peripheral blood from elderly subjects. Having demonstrated the utility of long-PCR banks, we are currently examining other mtDNA mutations using the long-PCR bank originating from the studied cohort.
